Treatment of Primary Epithelial Ovarian Cancer Abstract
Victoria YK CHAI1, Carmen KM CHOI2, Mandy MY CHU3, KY TSE3
1 Department of Obstetrics and Gynaecology, United Christian Hospital
2 Department of Obstetrics and Gynaecology, Pamela Youde Nethersole Eastern Hospital
3 Department of Obstetrics and Gynaecology, Queen Mary Hospital, The University of Hong Kong
1 Department of Obstetrics and Gynaecology, United Christian Hospital
2 Department of Obstetrics and Gynaecology, Pamela Youde Nethersole Eastern Hospital
3 Department of Obstetrics and Gynaecology, Queen Mary Hospital, The University of Hong Kong
Maximal cytoreduction and platinum-based chemotherapy remain the mainstay treatments for epithelial ovarian
cancer. New modalities include targeted therapy, intraperitoneal chemotherapy, and hyperthermic intraperitoneal
chemotherapy. With different characteristics in different patients and the complexity of diseases, treatment should
be individualised and reviewed by a multidisciplinary team.
Hong Kong J Gynaecol Obstet Midwifery 2018; 18(2):110–6
